-transparent.png){kind=logo}
Topically active carbonic anhydrase inhibitors. 4. [(Hydroxyalkyl)sulfonyl]benzene and [(hydroxyalkyl)sulfonyl]thiophenesulfonamides. 1991
K L Shepard, and
S L Graham, and
R J Hudcosky, and
S R Michelson, and
T H Scholz, and
H Schwam, and
A M Smith, and
J M Sondey, and
K M Strohmaier, and
R L Smith
Department of Medicinal Chemistry, Merck Sharp & Dohme Research Laboratories, West Point, Pennsylvania 19486.
For several decades a tantalizing goal for the treatment of primary open-angle glaucoma has been the development of a topically active carbonic anhydrase inhibitor. Recent results from several research groups indicate that considerable progress has been made toward this objective. In this report, we present the design and synthesis of (hydroxyalkyl)sulfonyl-substituted benzene- and thiophenesulfonamides. These compounds exhibit inhibition of carbonic anhydrase II in the nanomolar range and lower intraocular pressure in the alpha-chymotrypsinized rabbit model of ocular hypertension after topical instillation.
Related Publications
K L Shepard, and
S L Graham, and
R J Hudcosky, and
S R Michelson, and
T H Scholz, and
H Schwam, and
A M Smith, and
J M Sondey, and
K M Strohmaier, and
R L Smith
January 1991,
Archives of ophthalmology (Chicago, Ill. : 1960),
K L Shepard, and
S L Graham, and
R J Hudcosky, and
S R Michelson, and
T H Scholz, and
H Schwam, and
A M Smith, and
J M Sondey, and
K M Strohmaier, and
R L Smith
July 1993,
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
K L Shepard, and
S L Graham, and
R J Hudcosky, and
S R Michelson, and
T H Scholz, and
H Schwam, and
A M Smith, and
J M Sondey, and
K M Strohmaier, and
R L Smith
March 1991,
Ophthalmology,
K L Shepard, and
S L Graham, and
R J Hudcosky, and
S R Michelson, and
T H Scholz, and
H Schwam, and
A M Smith, and
J M Sondey, and
K M Strohmaier, and
R L Smith
December 1989,
Journal of medicinal chemistry,
K L Shepard, and
S L Graham, and
R J Hudcosky, and
S R Michelson, and
T H Scholz, and
H Schwam, and
A M Smith, and
J M Sondey, and
K M Strohmaier, and
R L Smith
November 1989,
Journal of medicinal chemistry,
K L Shepard, and
S L Graham, and
R J Hudcosky, and
S R Michelson, and
T H Scholz, and
H Schwam, and
A M Smith, and
J M Sondey, and
K M Strohmaier, and
R L Smith
January 1990,
Journal of ocular pharmacology,
K L Shepard, and
S L Graham, and
R J Hudcosky, and
S R Michelson, and
T H Scholz, and
H Schwam, and
A M Smith, and
J M Sondey, and
K M Strohmaier, and
R L Smith
September 2003,
Bioorganic & medicinal chemistry letters,
K L Shepard, and
S L Graham, and
R J Hudcosky, and
S R Michelson, and
T H Scholz, and
H Schwam, and
A M Smith, and
J M Sondey, and
K M Strohmaier, and
R L Smith
January 2008,
Current pharmaceutical design,
K L Shepard, and
S L Graham, and
R J Hudcosky, and
S R Michelson, and
T H Scholz, and
H Schwam, and
A M Smith, and
J M Sondey, and
K M Strohmaier, and
R L Smith
January 2001,
Drug design and discovery,
K L Shepard, and
S L Graham, and
R J Hudcosky, and
S R Michelson, and
T H Scholz, and
H Schwam, and
A M Smith, and
J M Sondey, and
K M Strohmaier, and
R L Smith
April 2009,
Bioorganic & medicinal chemistry letters,
